España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Sanofi
SNY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$54.21
0.06
0.11%
Pre-Market: 4:57 AM EDT
Get Report
Comment
Q4 2024 Earnings were released on Thu Jan 30th, before the market open
The most recent conference call was at 8:30 AM, 1 day ago
Click to view past webcast
Sanofi (SNY) Forecast
News
Earnings
Sanofi (SNY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Sanofi (NASDAQ:SNY) Stock
Sanofi Stock (NASDAQ: SNY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 31, 2025
Sanofi's Sarclisa Becomes First Anti-CD38 The...
Benzinga Newsdesk
Thursday, January 30, 2025
Trump Health Sec Nominee Kennedy Says He Will...
Benzinga Newsdesk
Sanofi shares are trading higher after the co...
Benzinga Newsdesk
Earnings Scheduled For January 30, 2025
Benzinga Insights
Sanofi 2025 Guidance: Sales To Grow Mid-To-Hi...
Benzinga Newsdesk
Sanofi Q4 2024 Adj. EPS $0.70 Misses $0.74 Es...
Benzinga Newsdesk
Tuesday, January 28, 2025
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Nabaparna Bhattacharya
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
Kaustubh Bagalkote
Friday, January 24, 2025
How Is The Market Feeling About Sanofi?
Benzinga Insights
Wednesday, January 22, 2025
Sanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses
Vandana Singh
EU Approves Sarclisa In Combination With VRd ...
Benzinga Newsdesk
Tuesday, January 21, 2025
Opella, Part Of Sanofi, Secures FDA Clearance...
Benzinga Newsdesk
Thursday, January 16, 2025
'As Bird Flu Affects More People And Animals,...
Benzinga Newsdesk
Monday, January 13, 2025
Sanofi's Sarclisa Gains First Approval In Chi...
Benzinga Newsdesk
Friday, January 10, 2025
Price Over Earnings Overview: Sanofi
Benzinga Insights
Thursday, January 09, 2025
Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma
Vandana Singh
Sanofi's Sarclisa Subcutaneous Formulation Ac...
Benzinga Newsdesk
Wednesday, January 08, 2025
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Chandrima Sanyal
Monday, January 06, 2025
'LDH Reports First U.S. H5N1-Related Human De...
Benzinga Newsdesk
Monday, December 30, 2024
How Is The Market Feeling About Sanofi?
Benzinga Insights
Wednesday, December 25, 2024
A Look Into Sanofi Inc's Price Over Earnings
Benzinga Insights
Monday, December 23, 2024
Sanofi Launches Phase 3 Trials For PCV21 And ...
Benzinga Newsdesk
Sunday, December 22, 2024
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Lekha Gupta
Friday, December 20, 2024
Cytokinetics Announces Sanofi's Acquisition O...
Benzinga Newsdesk
Wednesday, December 18, 2024
CA Governor Newsom Proclaimed State Of Emerge...
Benzinga Newsdesk
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Vandana Singh
CDC Confirms First Severe Case Of H5N1 Bird F...
Benzinga Newsdesk
Tuesday, December 17, 2024
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
Vandana Singh
Sanofi's 340B Credit Proposal Draws Federal Warning For Statutory Violation
Vandana Singh
Sanofi shares are trading higher after the co...
Benzinga Newsdesk
Teva And Sanofi Announce Primary Endpoints Me...
Benzinga Newsdesk
Friday, December 13, 2024
Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
Maureen Meehan
Novavax Advances Corporate Growth Strategy Th...
Benzinga Newsdesk
Sanofi's Tolebrutinib Achieves FDA Breakthrou...
Benzinga Newsdesk
Wednesday, December 11, 2024
Sanofi's Dual Influenza-COVID-19 Vaccines Rec...
Benzinga Newsdesk
Saturday, December 07, 2024
Sanofi Announced Rilzabrutinib Demonstrated S...
Benzinga Newsdesk
Friday, December 06, 2024
Reuters Agriculture & Energy Policy Reporter ...
Benzinga Newsdesk
Wednesday, December 04, 2024
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
Avi Kapoor
Tuesday, November 26, 2024
Bird Flu Found In Raw Milk Leads To Recall In California
Erica Kollmann
Friday, November 22, 2024
'Sanofi Plans To Change Hospital Drug-Discoun...
Benzinga Newsdesk
Wednesday, November 20, 2024
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
Vandana Singh
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
Hayden Buckfire
Monday, November 18, 2024
U.S. CDC Says Since April Confirmed Avian Inf...
Benzinga Newsdesk
Friday, November 15, 2024
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Vandana Singh
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Vandana Singh
Dupixent's sBLA Resubmission Accepted By FDA;...
Benzinga Newsdesk
Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
Chris Katje
Thursday, November 14, 2024
Sarclisa Recommended For EU Approval By The C...
Benzinga Newsdesk
Wednesday, November 13, 2024
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Vandana Singh
Show More